We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

93 hedge funds and large institutions have $244M invested in BioSpecifics Technologies Corp. in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 28 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

29% more capital invested

Capital invested by funds: $189M → $244M (+$54.3M)

21% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 28

16% more funds holding

Funds holding: 80 → 93 (+13)

Holders
93
Holders Change
+13
Holders Change %
+16.25%
% of All Funds
2.13%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
17
Increased
34
Reduced
28
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.22M
2
CCM
Cadence Capital Management
Massachusetts
+$2.52M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.31M
4
EP
Eversept Partners
New York
+$1.12M
5
EGI
EAM Global Investors
California
+$1.05M

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$8.98M
2
AQR Capital Management
AQR Capital Management
Connecticut
-$2.86M
3
ECP
Elk Creek Partners
Colorado
-$2.43M
4
Millennium Management
Millennium Management
New York
-$1.58M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
76
Metropolitan Life Insurance Company (MetLife)
New York
$123K +$107K +2,100 New
Citigroup
77
Citigroup
New York
$87K +$24.6K +483 +48%
JP Morgan Chase
78
JP Morgan Chase
New York
$78K +$22.2K +435 +48%
Ohio Public Employees Retirement System (OPERS)
79
Ohio Public Employees Retirement System (OPERS)
Ohio
$75K – – –
Legal & General Group
80
Legal & General Group
United Kingdom
$47K -$7.04K -138 -15%
Federated Hermes
81
Federated Hermes
Pennsylvania
$38K -$9.23K -181 -22%
AIP
82
Ameritas Investment Partners
Nebraska
$29K – – –
FANJ
83
Financial Architects (New Jersey)
New Jersey
$27K – – –
TRCT
84
Tower Research Capital (TRC)
New York
$26K +$20.5K +401 +872%
Walleye Trading
85
Walleye Trading
New York
$26K +$22.3K +438 New
AF
86
Allworth Financial
California
$12K – – –
Macquarie Group
87
Macquarie Group
Australia
$12K – – –
BNP Paribas Financial Markets
88
BNP Paribas Financial Markets
France
$10.5K – – –
Royal Bank of Canada
89
Royal Bank of Canada
Ontario, Canada
$5K +$3.62K +71 +645%
DA
90
Denali Advisors
California
$4K +$765 +15 +27%
SEI Investments
91
SEI Investments
Pennsylvania
$3K +$4.39K +86 +106%
PNC Financial Services Group
92
PNC Financial Services Group
Pennsylvania
$2K – – –
PA
93
Parallel Advisors
California
$1K – – –
Millennium Management
94
Millennium Management
New York
– -$1.58M -35,212 Closed
SCA
95
Secor Capital Advisors
New York
– -$592K -13,196 Closed
Manulife (Manufacturers Life Insurance)
96
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$241K -5,380 Closed
PIA
97
Piedmont Investment Advisors
North Carolina
– -$4K -99 Closed
1 2 3
4

BSTC Hedge Fund Activity: Q3 2018 in Review

93 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2018, worth a combined $244M — up 29% from $189M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BSTC positions and 4 closed out — a net gain of 13 holders — while 34 added to existing stakes and 28 trimmed.

The largest buyer was BlackRock, adding an estimated $4.22M. The largest seller was Stonepine Capital Management, cutting an estimated $8.98M.

  • 93 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2018, up from 80 in Q2 2018.
  • Funds reported $244M of BioSpecifics Technologies Corp. stock for Q3 2018, up 29% quarter-over-quarter.
  • 17 funds opened new BioSpecifics Technologies Corp. positions in Q3 2018 and 4 closed out, a net change of +13 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q3 2018 was BlackRock, an estimated $4.22M added.
  • The largest BioSpecifics Technologies Corp. seller in Q3 2018 was Stonepine Capital Management, an estimated $8.98M sold.

Based on aggregated 13F filings for Q3 2018.